Cite
HARVARD Citation
Ravaud, A. et al. (2017). A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study. European journal of cancer. pp. 110-117. [Online].